Skip to main content
Premium Trial:

Request an Annual Quote


Ž, a web-based drug development informatics service provider in San Jose, Calif., has appointed Boyd Poulsen, Dinesh Patel, and James O’Brien to its board of directors. Poulsen, chairman of’s board, had been senior vice-president of pharmaceutical development at Syntex (now Roche Global Development); Patel was founder and CEO of Theratech, which was acquired by Watson Pharmaceuticals last year; and O’Brien is president and CEO of O’Brien Marketing and Communications.

Filed under

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.